| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director | Director, Former 10% Owner
7 companies
Akkaraju Srinivas is a Director at SRRK with holdings across 7 companies. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $374.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2019 | SYRS Syros Pharmaceuticals, Inc. | Director | Buy | 533,332 | $7.50 | $3,999,990.00 | +50.3% | |
| Jan 31, 2018 | SYRS Syros Pharmaceuticals, Inc. | Director | Buy | 209,424 | $9.55 | $1,999,999.20 | +24.6% | |
| Dec 14, 2017 | SYRS Syros Pharmaceuticals, Inc. | Director | Buy | 109,774 | $9.03 | $991,557.60 | +4.9% | |
| May 12, 2015 | ATYR Atyr Pharma Inc | Director, Former 10% Owner | Buy | 320,000 | $14.00 | $4,480,000.00 | +20.7% |